MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-DL-02-0031333
Ipsi Pharmaceuticals Private Limited
Ipsi Pharmaceuticals Private Limited - trading in Delhi, India. Directors, charges & compliance details.
Revenue · FY 2023
₹7.79 Lakh
Latest filing
Net profit · FY 2023
₹4,214
Net margin 0.5%
EBITDA · FY 2023
₹18,218
EBITDA margin 2.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹40,000
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
3
As per MCA filings
Last financials
Mar 2023
Balance sheet date
About Ipsi Pharmaceuticals Private Limited
Data last updated:
Ipsi Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 09 June 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2022PTC399747.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹40,000. It is led by directors including Jatin Gautam and Rashid Ali.
Its last annual general meeting (AGM) was held on 20 November 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Shop No 14 Pocket A Csc Dda Market Dilshad Garden, Delhi, India – 110095.
As per the financials filed for FY 2023, the company reported a revenue of ₹7.79 Lakh. For the same year it recorded a net profit of ₹4,214 (net margin 0.5%) and EBITDA of ₹18,218 (EBITDA margin 2.3%).
Ipsi Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0031333).
Company Details of Ipsi Pharmaceuticals Private Limited
CIN U51909DL2022PTC399747
Registration Number 399747
Incorporation Date 09 June 2022
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 20 November 2023
Date of Balance Sheet 31 March 2023
MSME Classification Micro
Udyam Registration UDYAM-DL-02-0031333
Recognitions & Rankings of Ipsi Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No 14 Pocket A Csc Dda Market Dilshad Garden, Delhi, India – 110095
- IndustryTrading, Specialty, Wholesale
Comprehensive company report
Ipsi Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity
The main business activity of Ipsi Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Ipsi Pharmaceuticals Private Limited
FY 2023 filings availableIpsi Pharmaceuticals Private Limited reported revenue of ₹7.79 Lakh for FY 2023.
Revenue · FY 2023
₹7.79 Lakh
Net profit · FY 2023
₹4,214 margin 0.5%
EBITDA · FY 2023
₹18,218 margin 2.3%
Financial Statement Summary
| Metrics | FY 2022-23 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | •••• |
| Other Income | •••• |
| Total Revenue | •••• |
| Cost of Materials Consumed | •••• |
| Employee Benefit Expense | •••• |
| Finance Costs | •••• |
| Depreciation and Amortisation | •••• |
| Other Expenses | •••• |
| Total Expenses | •••• |
| EBITDA | ₹18,218 |
| Profit Before Tax | •••• |
| Tax Expense | •••• |
| Net Profit (PAT) | ₹4,214 |
| Balance Sheet | |
| Share Capital | •••• |
| Reserves and Surplus | •••• |
| Net Worth (Total Equity) | •••• |
| Long-term Borrowings | •••• |
| Short-term Borrowings | •••• |
| Trade Payables | •••• |
| Total Liabilities | •••• |
| Fixed Assets | •••• |
| Investments | •••• |
| Inventories | •••• |
| Trade Receivables | •••• |
| Cash and Bank Balance | •••• |
| Total Assets | •••• |
Financial Ratios
| Metrics | FY 2022-23 |
|---|---|
| Profitability | |
| EBITDA Margin | 2.3% |
| Net Profit Margin | 0.5% |
| Return on Equity (ROE) | •••• |
| Return on Capital Employed (ROCE) | •••• |
| Return on Assets (ROA) | •••• |
| Liquidity and Debt | |
| Current Ratio | •••• |
| Quick Ratio | •••• |
| Debt-to-Equity Ratio | •••• |
| Interest Coverage Ratio | •••• |
| Efficiency and Growth | |
| Asset Turnover | •••• |
| Receivable Days | •••• |
| Payable Days | •••• |
| Inventory Days | •••• |
| Revenue Growth | •••• |
| Net Profit Growth | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ipsi Pharmaceuticals are in the company report.
: available in the company report
Board of Directors of Ipsi Pharmaceuticals Private Limited
Ipsi Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Salma Parveen | Additional Director | 26 Feb 2024 | 2 Years 7 Months | Current |
| Jatin Gautam | Director | 09 Jun 2022 | 4 Years 4 Months | Current |
| Rashid Ali | Director | 09 Jun 2022 | 4 Years 4 Months | Current |
Peer Comparison
Ipsi Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Druson Pharmaceuticals Private Limited | ₹7.83 Lakh (FY 2024) | •••• | •••• | •••• | Una, Himachal Pradesh, India | |
| Xenik Pharmaceuticals Private Limited | ₹7.81 Lakh (FY 2019) | •••• | •••• | •••• | Silchar, Assam, India | |
| Ipsi Pharmaceuticals Private Limited this company | ₹7.79 Lakh (FY 2023) | •••• | •••• | •••• | Delhi, India | |
| S D G Drugs Pharmaceuticals Private Limited | ₹7.7 Lakh (FY 2018) | •••• | •••• | 37.0% | •••• | Agra, Uttar Pradesh, India |
Peers are the companies nearest to Ipsi Pharmaceuticals by revenue, above and below it, in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings
Ipsi Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Ipsi Pharmaceuticals.
: available in the company report
Recent Activity
Ipsi Pharmaceuticals Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Salma Parveen was appointed as Additional Director on 26 Feb 2024.
Appointed
Salma Parveen was appointed as Additional Director.
AGM
Ipsi Pharmaceuticals Private Limited last Annual general meeting of members was held on 20 Nov 2023 as per latest MCA records.
Filing
Ipsi Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi I.
Appointed
Jatin Gautam was appointed as Director.
Appointed
Rashid Ali was appointed as Director.
Incorporation
09 Jun 2022
Ipsi Pharmaceuticals Private Limited was registered on 09 Jun 2022 with Roc Delhi I & aged 4 years 4 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Ipsi Pharmaceuticals is an active private limited company based in Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 09 June 2022 (4+ years old) and is registered under CIN U51909DL2022PTC399747.
Ipsi Pharmaceuticals has 3 current directors:
- Salma Parveen - Additional Director
- Jatin Gautam - Director
- Rashid Ali - Director
The latest financial statements of Ipsi Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 20 November 2023. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Ipsi Pharmaceuticals is U51909DL2022PTC399747. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ipsi Pharmaceuticals was incorporated on 09 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ipsi Pharmaceuticals by revenue are Druson Pharmaceuticals Private Limited, Xenik Pharmaceuticals Private Limited, S D G Drugs Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Salma Parveen was appointed as Additional Director on 26 Feb 2024. Jatin Gautam was appointed as Director on 09 Jun 2022. Rashid Ali was appointed as Director on 09 Jun 2022.
Yes, Ipsi Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0031333).
The registered office of Ipsi Pharmaceuticals is at Shop No 14 Pocket A Csc Dda Market Dilshad Garden, Delhi, India – 110095.
Ipsi Pharmaceuticals operates in the trading industry, in the specialty segment.
Ipsi Pharmaceuticals can be reached at its registered office: Shop No 14 Pocket A Csc Dda Market Dilshad Garden, Delhi, India – 110095.